Stevens Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-18,738
| Closed | -$1.26M | – | 608 |
|
|
2019
Q3 | $1.26M | Sell |
18,738
-968
| -5% | -$65.2K | 0.11% | 195 |
|
|
2019
Q2 | $1.69M | Sell |
19,706
-17,240
| -47% | -$1.48M | 0.08% | 279 |
|
|
2019
Q1 | $3.28M | Buy |
+36,946
| New | +$3.28M | 0.14% | 194 |
|
|
2017
Q4 | – | Sell |
-20,048
| Closed | -$1.87M | – | 826 |
|
|
2017
Q3 | $1.87M | Sell |
20,048
-4,118
| -17% | -$383K | 0.07% | 325 |
|
|
2017
Q2 | $2.2M | Buy |
24,166
+19,116
| +379% | +$1.74M | 0.08% | 295 |
|
|
2017
Q1 | $443K | Buy |
+5,050
| New | +$443K | 0.02% | 608 |
|
|
2016
Q4 | – | Sell |
-5,040
| Closed | -$466K | – | 880 |
|
|
2016
Q3 | $466K | Sell |
5,040
-1,032
| -17% | -$95.4K | 0.02% | 588 |
|
|
2016
Q2 | $472K | Buy |
+6,072
| New | +$472K | 0.02% | 594 |
|
|
2015
Q4 | – | Sell |
-32,382
| Closed | -$3.41M | – | 933 |
|
|
2015
Q3 | $3.41M | Buy |
+32,382
| New | +$3.41M | 0.16% | 158 |
|
|
2014
Q3 | – | Sell |
-9,405
| Closed | -$585K | – | 1006 |
|
|
2014
Q2 | $585K | Buy |
+9,405
| New | +$585K | 0.02% | 623 |
|
|
2014
Q1 | – | Sell |
-31,715
| Closed | -$2.23M | – | 1071 |
|
|
2013
Q4 | $2.23M | Sell |
31,715
-13,260
| -29% | -$933K | 0.07% | 320 |
|
|
2013
Q3 | $3.25M | Sell |
44,975
-13,462
| -23% | -$972K | 0.1% | 262 |
|
|
2013
Q2 | $3.26M | Buy |
+58,437
| New | +$3.26M | 0.11% | 230 |
|